Bio

Barry Dunn is a Managing Director of The Peakstone Group, having previously served the firm as a Senior Advisor. He has extensive principal investment and capital markets experience, notably as a Managing Director of GTCR, LLC where he launched the firm’s Capital Markets function, pioneering the role of dedicated Capital Markets Partner in the private equity industry. At GTCR, Barry raised over $15 billion in senior debt, junior debt, and third-party equity capital to support dozens of platform investments, add-on acquisitions and recapitalizations. He also led GTCR Capital Partners, L.P., a $450 million mezzanine debt investment fund, served on GTCR’s investment committee and LP Advisory committee, and held board positions at two portfolio companies. Following GTCR, Barry joined with two former GTCR executives to start R Squared Capital, created to pursue small to medium-sized assets in the payments and fintech space. He also served as advisor, board member and VP of Development of medical device startup Berkshire Biomedical, currently pursuing FDA approval for its biometrics-driven prescription drug delivery device. Prior to GTCR, he held positions with Bank of America and Bankers Trust Company. Barry earned an MBA in Finance from Duke University, and a BA in Economics from Washington & Lee University.